Inventor · disambiguated record
Mark F. Maurer
Also filed as: MAURER MARK · MAURER MARK D · MAURER MARK F
22 granted patents·13 pending applications·258 citations·filing 1999–2023
96Inventor score
Files withALPINE IMMUNE SCIENCES INC14ZYMOGENETICS INC11BRISTOL MYERS SQUIBB CO7MAURER MARK D1SPRECHER CINDY A1
Top patents by PatentIndex Score
35 records- 0198US11230588B2CD80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2021·Granted Jan 25, 2022·6 cites·29 claims
- 0298US11117949B2CD80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2021·Granted Sep 14, 2021·13 cites·30 claims
- 0398US11117950B2CD80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2021·Granted Sep 14, 2021·13 cites·28 claims
- 0498US11117948B2CD80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2021·Granted Sep 14, 2021·13 cites·30 claims
- 0598US11096988B2CD80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2021·Granted Aug 24, 2021·13 cites·19 claims
- 0698US7521537B2Cytokine receptor zcytor17ZYMOGENETICS INC·Filed 2006·Granted Apr 21, 2009·43 cites·8 claims
- 0798US7495080B2Cytokine receptor zcytor17ZYMOGENETICS INC·Filed 2006·Granted Feb 24, 2009·43 cites·11 claims
- 0898US7427494B2Nucleic acid encoding cytokine receptor zcytor17ZYMOGENETICS INC·Filed 2006·Granted Sep 23, 2008·39 cites·15 claims
- 0997US10189902B2Antibodies to TIGITBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jan 29, 2019·27 cites·8 claims
- 1095US9644032B2Antibodies against OX40 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2016·Granted May 9, 2017·12 cites·30 claims
- 1194US11639375B2CD80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2018·Granted May 2, 2023·4 cites·28 claims
- 1293US7947474B2Nucleic acid encoding cytokine receptor ZCYTOR17ZYMOGENETICS INC·Filed 2006·Granted May 24, 2011·10 cites·17 claims
- 1392US8648182B2Polynucleotides encoding antibodies to cytokine receptor zcytor17ZYMOGENETICS INC·Filed 2012·Granted Feb 11, 2014·5 cites·5 claims
- 1488US8309692B2Antibodies to cytokine receptor ZCYTOR17SPRECHER CINDY A·Filed 2011·Granted Nov 13, 2012·6 cites·6 claims
- 1583US11466092B2Antibodies against OX-40 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Oct 11, 2022·1 cites·19 claims
- 1683US11008390B2Antibodies to TIGITBRISTOL MYERS SQUIBB CO·Filed 2018·Granted May 18, 2021·2 cites·16 claims
- 1782US2024002466A1Cd80 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2023·Application pending·0 cites
- 1881US10683357B2Antibodies against OX40 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jun 16, 2020·1 cites·19 claims
- 1978US11471488B2CD155 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2017·Granted Oct 18, 2022·1 cites·22 claims
- 2078US2023272100A1Antibodies against ox-40 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 2177US11732022B2PD-L2 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2018·Granted Aug 22, 2023·1 cites·9 claims
- 2273US11834490B2CD112 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2017·Granted Dec 5, 2023·1 cites·35 claims
- 2371US2005214801A1Nucleic acid encoding cytokine receptor zcytor17ZYMOGENETICS INC·Filed 2004·Application pending·0 cites
- 2470US12060421B2Antibodies to TIGITBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Aug 13, 2024·0 cites·6 claims
- 2564US2007048303A1Nucleic acid encoding cytokine receptor zcytor17ZYMOGENETICS INC·Filed 2006·Application pending·0 cites
- 2664US2007141051A1Nucleic acid encoding cytokine receptor zcytor17ZYMOGENETICS INC·Filed 2006·Application pending·0 cites
- 2763US2025243260A1Immunomodulatory proteins of variant cd80 polypeptides, cell therapies and related methods and usesALPINE IMMUNE SCIENCES INC·Filed 2023·Application pending·0 cites
- 2861US2023381229A1Cd155 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2022·Application pending·0 cites
- 2960US2004142422A1Cytokine receptor zcytor17ZYMOGENETICS INC·Filed 2004·Application pending·0 cites
- 3060US2003096339A1Cytokine receptor zcytor17Filed 2001·Application pending·0 cites
- 3155US2023220039A1Pd-l1 variant immunomodulatory proteins and uses thereofALPINE IMMUNE SCIENCES INC·Filed 2018·Application pending·0 cites
- 3248US2007105777A1Cytokine receptor zcytor17ZYMOGENETICS INC·Filed 2007·Application pending·0 cites
- 3347US6372889B1Soluble protein ZTMPO-1ZYMOGENETICS INC·Filed 1999·Granted Apr 16, 2002·4 cites·5 claims
- 3447US2022177587A1Methods and uses of variant cd80 fusion proteins and related constructsALPINE IMMUNE SCIENCES INC·Filed 2019·Application pending·0 cites
- 3545US2007044209A1Genital support deviceMAURER MARK D·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark F. Maurer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →